14,024 Shares in Celsius Holdings Inc. (NASDAQ:CELH) Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH purchased 14,024 shares of Celsius Holdings Inc. in the 1st quarter, valued at approximately $500,000.
• Equities analysts are optimistic about Celsius, with multiple firms raising their target prices; UBS increased theirs from $49.00 to $57.00, indicating a "buy" rating.
• Celsius reported a quarterly revenue of $329.28 million, which was below analysts' expectations of $349.09 million, marking a 7.4% decline compared to the same period the previous year.

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 14,024 shares of the company's stock, valued at approximately $500,000.

Several other institutional investors have also added to or reduced their stakes in CELH. Westside Investment Management Inc. purchased a new position in shares of Celsius in the 1st quarter worth approximately $32,000. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Celsius by 255.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after purchasing an additional 750 shares during the period. UMB Bank n.a. boosted its holdings in shares of Celsius by 145.0% in the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock worth $51,000 after purchasing an additional 844 shares during the period. Fifth Third Bancorp boosted its holdings in shares of Celsius by 62.9% in the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after purchasing an additional 666 shares during the period. Finally, Peterson Wealth Services purchased a new position in shares of Celsius in the 1st quarter worth approximately $66,000. Hedge funds and other institutional investors own 60.95% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. UBS Group lifted their target price on Celsius from $49.00 to $57.00 and gave the stock a "buy" rating in a report on Thursday, July 17th. TD Cowen upgraded Celsius from a "hold" rating to a "buy" rating and lifted their target price for the stock from $37.00 to $55.00 in a report on Monday, June 16th. Truist Financial boosted their price objective on Celsius from $50.00 to $55.00 and gave the company a "buy" rating in a report on Monday, July 14th. Citigroup began coverage on Celsius in a report on Wednesday, July 23rd. They set a "buy" rating and a $55.00 price objective for the company. Finally, Stifel Nicolaus boosted their price objective on Celsius from $47.00 to $50.00 and gave the company a "buy" rating in a report on Tuesday, July 29th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $47.83.

Celsius Trading Down 1.4%

Shares of CELH stock opened at $44.72 on Friday. Celsius Holdings Inc. has a twelve month low of $21.10 and a twelve month high of $48.47. The stock has a market capitalization of $11.53 billion, a price-to-earnings ratio of 139.75, a P/E/G ratio of 1.58 and a beta of 1.40. The stock has a fifty day simple moving average of $43.50 and a two-hundred day simple moving average of $35.45.

Celsius (NASDAQ:CELH - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.02). Celsius had a return on equity of 42.12% and a net margin of 8.40%. The firm had revenue of $329.28 million during the quarter, compared to analysts' expectations of $349.09 million. During the same quarter in the prior year, the company posted $0.27 earnings per share. Celsius's quarterly revenue was down 7.4% compared to the same quarter last year. Research analysts predict that Celsius Holdings Inc. will post 0.89 EPS for the current fiscal year.

Insiders Place Their Bets

In other Celsius news, major shareholder Deborah Desantis sold 100,000 shares of the company's stock in a transaction on Monday, July 28th. The stock was sold at an average price of $47.00, for a total value of $4,700,000.00. Following the completion of the sale, the insider directly owned 17,917,770 shares in the company, valued at approximately $842,135,190. This represents a 0.56% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO John Fieldly sold 130,803 shares of the company's stock in a transaction on Tuesday, June 24th. The stock was sold at an average price of $45.00, for a total value of $5,886,135.00. Following the completion of the sale, the chief executive officer owned 1,038,577 shares of the company's stock, valued at $46,735,965. This represents a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 762,974 shares of company stock worth $35,158,418. 2.55% of the stock is currently owned by company insiders.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.